newsfilter
← Latest News
GlobeNewswire·

Aequus and reVision to Collaborate on Stargardt Disease Program

VANCOUVER, British Columbia and RIDGEWOOD, N.J., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus") and reVision Therapeutics, Inc. ("reVision") announce a collaboration on the development of a therapy for